Literature DB >> 14732926

Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysis.

Herman van Dekken1, Pamela L Paris, Donna G Albertson, Janneke C Alers, Armann Andaya, David Kowbel, Theodorus H van der Kwast, Daniel Pinkel, Fritz H Schröder, Kees J Vissers, Mark F Wildhagen, Colin Collins.   

Abstract

Prostate cancer is known for its highly heterogeneous histological appearance. Data concerning the cytogenetic content of areas with different histology are sparse. We have genetically evaluated 10 prostatic adenocarcinomas with intermediate histopathological grades (Gleason score 7) that showed two distinctive growth patterns with different pathologies, that is, Gleason grades 3 and 4 (G3 and G4). The G3 and G4 tumor specimens were taken from spatially separated regions within the cancer mass. Array-based comparative genomic hybridization (aCGH) was performed to obtain genotypes from the 10 pairs of G3 and G4 cancer areas. The cancer DNAs were retrieved from formalin-fixed and paraffin-embedded tissues allowing optimal recognition and selection of target cells. A genome-wide 2,400-element BAC array that provided high-resolution detection of both deletions and amplifications was used. In the 20 G3 and G4 areas, 252 genomic aberrations (88 gains, 164 deletions) were noted, of which 86 were concurrent in G3 and G4 areas (34% overlap). Ninety-five of the 252 alterations were defined by a single BAC clone (54 gains, 41 deletions). Overlapping changes were more frequent for deletions (46%) than for gains (13%). Frequent coinciding deletions (> or = 20% of tumors) were seen on 8p (60%), 6q (30%), 1p (20%), 2q (20%), proximal 8q (20%), 10q (20%), 13q (20%), 16q (20%), and 18q (20%). A frequent overlapping gain (> or = 20% of tumors) was detected on distal 13q (20%). The patterns of imbalance could be found to coincide in the G3 and G4 areas of the majority of cancers. Array-based CGH can be used as a tool for the evaluation of genetic patterns in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732926     DOI: 10.1002/gcc.20001

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

1.  Expression of DDX27 contributes to colony-forming ability of gastric cancer cells and correlates with poor prognosis in gastric cancer.

Authors:  Yoshiyuki Tsukamoto; Shoichi Fumoto; Tsuyoshi Noguchi; Kazuyoshi Yanagihara; Yuka Hirashita; Chisato Nakada; Naoki Hijiya; Tomohisa Uchida; Keiko Matsuura; Ryoji Hamanaka; Kazunari Murakami; Masao Seto; Masafumi Inomata; Masatsugu Moriyama
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

2.  Array-based comparative genomic hybridization from formalin-fixed, paraffin-embedded breast tumors.

Authors:  Sandy Devries; Sarah Nyante; Jim Korkola; Richard Segraves; Kentaro Nakao; Dan Moore; Hanik Bae; Monica Wilhelm; Shelley Hwang; Frederic Waldman
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

3.  Meta-analysis of Aurora Kinase A (AURKA) Expression Data Reveals a Significant Correlation Between Increased AURKA Expression and Distant Metastases in Human ER-positive Breast Cancers.

Authors:  Heinz-Ulli G Weier; Jian-Hua Mao
Journal:  J Data Mining Genomics Proteomics       Date:  2013-03-06

4.  The Molecular Taxonomy of Primary Prostate Cancer.

Authors: 
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

5.  Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer.

Authors:  Yuval Tabach; Ira Kogan-Sakin; Yosef Buganim; Hilla Solomon; Naomi Goldfinger; Randi Hovland; Xi-Song Ke; Anne M Oyan; Karl-H Kalland; Varda Rotter; Eytan Domany
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

6.  The use of whole genome amplification to study chromosomal changes in prostate cancer: insights into genome-wide signature of preneoplasia associated with cancer progression.

Authors:  Simon Hughes; Maisa Yoshimoto; Ben Beheshti; Richard S Houlston; Jeremy A Squire; Andrew Evans
Journal:  BMC Genomics       Date:  2006-03-30       Impact factor: 3.969

7.  Comparison of chromosomal and array-based comparative genomic hybridization for the detection of genomic imbalances in primary prostate carcinomas.

Authors:  Franclim R Ribeiro; Rui Henrique; Merete Hektoen; Marianne Berg; Carmen Jerónimo; Manuel R Teixeira; Ragnhild A Lothe
Journal:  Mol Cancer       Date:  2006-09-04       Impact factor: 27.401

8.  Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.

Authors:  Joern Kamradt; Volker Jung; Kerstin Wahrheit; Laura Tolosi; Joerg Rahnenfuehrer; Martin Schilling; Robert Walker; Sean Davis; Michael Stoeckle; Paul Meltzer; Bernd Wullich
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

9.  FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.

Authors:  M Yoshimoto; I W Cunha; R A Coudry; F P Fonseca; C H Torres; F A Soares; J A Squire
Journal:  Br J Cancer       Date:  2007-08-14       Impact factor: 7.640

10.  FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7.

Authors:  Zeran Wang; Yueyong Liu; Pengju Zhang; Weiguo Zhang; Weijing Wang; Kenneth Curr; Guangwei Wei; Jian-Hua Mao
Journal:  Oncotarget       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.